Researchers tested an AI-designed drug that might be able to wind back our biological clock. Ian explains why this is such a ...

What if the next big target in medicine is getting older itself? Researchers are taking that possibility seriously, with new tools, new clinics, and growing FDA attention. Instead of waiting for ...

The First Steps Towards Cellular Rejuvenation Life Biosciences, a biotech startup based in Boston, has announced that their ...

Spread the loveImagine a future where the relentless march of time, etched into our cells, could be rewound. It sounds like ...

The Four-Week Meal Makeover In a new study conducted by researchers at the University of Sydney, 104 adults aged 65 to 75 ...

Modernization planning has usually started with a discovery period: interviewing experts, reading old documents, inspecting ...

AI is accelerating longevity research through drug discovery, protein redesign and biological-age testing, but experts caution that early laboratory and clinical signals do not yet prove longer, ...

Amrize stock is a "Hold" since its valuation implies low EBITDA growth. Learn more about the insider buying and upside potential.

Spread the love“`html Imagine a future where the relentless march of time, etched into our very cells, could be turned back.

Just like us, our cells can get old. But while these senescent cells stop dividing, they linger on, which is one reason they're sometimes called "zombie cells." Zombie cells aren't functionally ...

The aging brain may not be as doomed as we thought—at least for people with extraordinary memory.

A new conditional knockout mouse model shows that loss of the epigenetic regulator Tet2, combined with aging and a reshaped ...